From Health Affairs Today <[email protected]>
Subject Lab Benefit Managers For Genetic Testing; Alcohol Misuse And Subsequent Arrest For Intimate Partner Violence
Date October 23, 2019 8:14 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
 

View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Wednesday, October 23, 2019**

[link removed]

TODAY ON THE BLOG

****PHARMACEUTICALS & MEDICAL TECHNOLOGY

The Emerging Use By Commercial Payers Of Third-Party Lab Benefit
Managers For Genetic Testing

By Kathryn A. Phillips and Patricia A. Deverka

Commercial payers are increasingly using laboratory benefit managers to
manage laboratory test utilization. LBMs represent a relatively newer
area of utilization management, although they are similar in some ways
to pharmacy benefit managers, used to manage prescription drug benefits.
Read More >>

[link removed]

IN THE JOURNAL

VIOLENCE

Alcohol-Related Crimes And Risk Of Arrest For Intimate Partner Violence
Among California Handgun Purchasers

By Hannah Laqueur, Rose M. C. Kagawa, Mona Wright, and Garen J.
Wintemute

Hannah Laqueur and coauthors explore the relationship between alcohol
misuse and subsequent arrest for intimate partner violence. Read More >>

Read the October 2019 Table of Contents

****

****

Subscribe to Health Affairs

**for full journal access**

HEALTH AFFAIRS EVENTS

CULTURE OF HEALTH: HOUSING AND HEALTH

Registration Now Open!
November 7
9:00 am - 11:00 am Eastern
W Hotel Washington
515 15th Street NW, Washington DC
Register Today

Since 2015, Health Affairs has published important work related to a
"Culture of Health." The November 7 briefing will highlight the
relationship between housing and health by featuring panels of
contributing authors and practitioners who are meeting the challenges.
Join this robust discussion on how community and place play an important
role in promoting health and preventing disease.
View Speakers

Getevent-specific emails
delivered directly to your inbox.

****

A CLOSER LOOK-Alzheimer's Disease

Drug company Biogen announced that it would seek FDA approval for
aducanumab, a drug intended to treat early Alzheimer's disease by
helping clear plaque from the brain. In the April 2014 issue of Health
Affairs, Jonathan Bor explored why it has proven so difficult to make
progress toward a treatment
and
potential cure for the disease.

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I
Screenshot of the email generated on import

Message Analysis